Silence Therapeutics Income Statement (2018-2025) | SLN

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2018 Jun2019 Dec2019 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter)
0.00B3,775.26B0.00B0.00B0.01B0.00B0.00B0.01B0.01B0.01B0.00B0.00B0.02B0.00B0.00B0.03B0.00B0.00B0.00B0.00B
Cost of Revenue (Quarter)
0.00B2,550.85B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Gross Profit (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.00B0.00B0.01B-0.00B-0.00B0.02B0.00B0.00B0.00B0.00B
Operating items
Research & Development (Quarter)
-10.28B-0.01B-0.01B0.07B-0.01B-0.01B-0.01B0.07B-0.02B-0.02B-0.01B0.10B0.01B0.01B0.01B0.04B0.01B0.02B0.01B0.03B
Selling, General & Administrative (Quarter)
-5.17B-0.01B-0.01B0.05B-0.01B-0.01B-0.01B0.04B-0.01B-0.01B-0.01B0.05B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.00B
Restructuring Costs (Quarter)
0.00B-0.00B
Other Operating Expenses (Quarter)
-0.02B-0.02B-0.02B
Operating Expenses (Quarter)
-15.45B-0.02B-0.02B0.12B-0.02B-0.02B-0.02B0.12B-0.02B-0.02B-0.02B0.14B-0.00B-0.00B-0.03B0.05B0.00B0.00B0.02B0.03B
Operating Income (Quarter)
-0.00B-0.02B-16934.52B-0.02B-0.01B-0.02B-0.02B-0.01B-0.01B-0.01B-0.02B-0.02B-0.01B-0.02B-0.03B0.05B-0.03B-0.02B-0.03B0.06B
EBIT (Quarter)
-0.00B-0.02B-16934.52B-0.02B-0.01B-0.02B-0.02B-0.01B-0.01B-0.01B-0.02B-0.02B-0.01B-0.02B-0.03B0.05B-0.03B-0.02B-0.03B0.06B
Non-operating items
Non Operating Investment Income (Quarter)
-0.00B
Interest & Investment Income (Quarter)
0.00B0.00B0.00B0.00B-0.00B0.00B0.01B-0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Other Non Operating Income (Quarter)
0.36B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B0.00B0.00B-0.01B-0.00B0.00B-0.01B0.00B0.00B
Net income details
EBT (Quarter)
-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.00B-0.02B-0.04B0.01B-0.03B-0.03B-0.02B0.08B
Tax Provisions (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B
Profit After Tax (Quarter)
-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.00B-0.02B-0.04B0.01B-0.03B-0.03B-0.02B-0.01B
Income from Continuing Operations (Quarter)
-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.00B-0.02B-0.04B0.01B-0.03B-0.03B-0.02B0.08B
Consolidated Net Income (Quarter)
-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.00B-0.02B-0.04B0.01B-0.03B-0.03B-0.02B0.08B
Income towards Parent Company (Quarter)
-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.00B-0.02B-0.04B0.01B-0.03B-0.03B-0.02B0.08B
Net Income towards Common Stockholders (Quarter)
-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.00B-0.02B-0.04B0.01B-0.03B-0.03B-0.02B0.08B
Additional items
EPS (Basic) (Quarter)
-2.83-2.68-2.50-2.13-2.99-1.73-0.16-2.35-2.18-1.84-0.13-0.02-0.14-0.250.09-0.20-0.19-0.15-0.09
EPS (Weighted Average and Diluted) (Quarter)
-0.16-0.13-0.02-0.14-0.250.09-0.20-0.19-0.15-0.09
Shares Outstanding (Weighted Average) (Quarter)
0.01B0.01B0.01B0.01B0.01B0.01B0.11B0.01B0.01B0.01B0.14B0.17B0.18B0.18B0.14B0.14B0.14B0.14B0.14B
Shares Outstanding (Diluted Average) (Quarter)
0.11B0.14B0.17B0.17B0.18B0.14B0.14B0.14B0.14B0.14B
EBITDA (Quarter)
-0.00B-0.02B-16934.52B-0.02B-0.01B-0.02B-0.02B-0.01B-0.01B-0.01B-0.02B-0.02B-0.01B-0.02B-0.03B0.05B-0.03B-0.02B-0.03B0.06B
Tax Rate (Quarter)
-11.80%-1.17%-0.14%2.57%-0.04%0.00%